COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,225 Articles (22,733 medRxiv, 8,492 bioRxiv)

Most recent first Previous |  Page 338: Articles 3371-3380  | Next

VirEvol platform:accurate prediction and visualization of SARS-CoV-2 evolutionary trajectory based on protein language model, structural information and immunological recognition mechanism
Zheng, X., Zhang, L., Ning, Z., Qiu, Y., Dong, R., Li, X., Lv, L., Xu, H., Wang, Y., Ma, B.
10.1101/2023.09.15.557978 — Posted: 2023-09-17
Assessing the impact of the Gamma variant on COVID-19 Patient admissions in a Southern Brazilian tertiary hospital - A comparison of dual pandemic phases
Domino, N. R., Lapinscki, B. A., Zhen, F., Yamaguto, G., Costa, E. C. S., Moriya, V. L., Pereira, L. A., Petterle, R., Nogueira, M. B., Raboni, S. M.
10.1101/2023.09.13.23295114 — Posted: 2023-09-15
Enhanced production of eicosanoids in plasma and activation of DNA damage pathways in PBMCs are correlated with the severity of ancestral COVID-19 infection
Tomalka, J. A., Owings, A., Galeas-Pena, M., Ziegler, C. G. K., Robinson, T. O., Wichman, T. G., Laird, H., Williams, H. B., Dhaliwal, N. S., Everman, S., Zafar, Y., Shalek, A., Horwitz, B. H., Ordovas-Montanes, J., Glover, S. C., Gibert, Y.
10.1101/2023.09.14.23295549 — Posted: 2023-09-15
Refining COVID-19 retrospective diagnosis with continuous serological tests: a Bayesian mixture model
Glemain, B., de Lamballerie, X., Zins, M., Severi, G., Touvier, M., Deleuze, J.-F., SAPRIS-SERO study group, , Lapidus, N., Carrat, F.
10.1101/2023.09.15.23295603 — Posted: 2023-09-15
Predictors of COVID-19 Vaccine Acceptability Among Refugees and Other Migrant Populations: A Systematic Scoping Review
Yazdani, Y., Pai, P., Sayfi, S., Mohammadi, A., Perdes, S., Spitzer, D., Fabreau, G., Pottie, K.
10.1101/2023.09.15.23295608 — Posted: 2023-09-15
Clinical Performance of SARS-CoV-2 Rapid Antigen Tests: A Systematic Review and Meta-Analysis
Feng, Q., Germic, N., Hayer, J.
10.1101/2023.09.15.23295560 — Posted: 2023-09-15
MixOmics Integration of Biological Datasets Identifies Highly Correlated Key Variables of COVID-19 severity.
Harriott, N. C., Chimenti, M. S., Ryan, A. L.
10.1101/2023.09.14.557558 — Posted: 2023-09-15
Cooperativity and induced oligomerisation control the interaction of SARS- CoV-2 with its cellular receptor and patient-derived antibodies
Asor, R., Olerinyova, A., Burnap, S. A., Kushwah, M. S., Soltermann, F., Rudden, L. P., Hensen, M., Vasiljevic, S., Brun, J., Hill, M., Chang, L., Dejnirattisai, W., Supasa, P., Mongkolsapaya, J., Zhou, D., Stuart, D. I., Screaton, G., Degiacomi, M., Zitzmann, N., Benesch, J. L., Struwe, W. B., Kukura, P.
10.1101/2023.09.14.557399 — Posted: 2023-09-15
The SARS-CoV-2 nucleoprotein associates with anionic lipid membranes
Dutta, M., Su, Y., Voth, G. A., Stahelin, R. V.
10.1101/2023.09.15.557899 — Posted: 2023-09-15
Enhanced neutralization of SARS-CoV-2 XBB sub-lineages and BA.2.86 by a tetravalent COVID-19 vaccine booster
Wang, X., Jiang, S., Ma, W., Li, X., Wei, K., Xie, F., Zhao, C., Zhao, X., Li, C., Qiao, R., Cui, Y., Chen, Y., Li, J., Cai, G., Liu, C., Hu, Z., Zhang, W., Li, M., Zhang, Y., Wang, P.
10.1101/2023.09.14.557682 — Posted: 2023-09-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).